Your Account
close button

Use our patient tools for secure, convenient, 24/7 access. Learn more

OR

This facility is a member of


Connect with us:

Liver Cancer Trial

   

A Phase II Randomized Double-Blind Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular (HCC) in Patients with and without Vascular Invasion [ECOG 1208]

Principal Investigator:
Elyse Schneiderman, MD
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan WIlson, RN

A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients with Potentially-Resectable Hepatic Colorectal Metastases [NSABP C-11]

Principal Investigator:
Elyse Schneiderman, MD
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan WIlson, RN
 

Share